Comparative merits of two topical corticosteroid antimicrobial drugs.
The anti-inflammatory and antimicrobial activities of two topical creams, one containing halcinonide, neomycin and nystatin (HNN), and the other betamethasone valerate, gentamicin, iodochlorhydroxyquin and tolnaftate (BGI), were compared in a randomized, parallel study of 154 patients (eighty-seven secondarily infected eczematous dermatoses; sixty-seven cutaneous candidiasis). Repeated clinical assessments showed that the two creams produced equivalent therapeutic responses both in patients with infected eczematous lesions and candidiasis. HNN and BGI creams eradicated the bacterial pathogens isolated prior to treatment in 80% and 76%, respectively, of the patients with eczematous dermatoses. The organism most frequently isolated in these patients was S. aureus. Local irritation prompting discontinuance of therapy occurred in just one patient receiving HNN, and two patients receiving BGI.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001624:Betamethasone Valerate / Q000008:administration & dosage; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D002986:Clinical Trials as Topic; D007464:Clioquinol / Q000008:administration & dosage; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage; D006206:Halcinonide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009355:Neomycin / Q000008:administration & dosage; D009761:Nystatin / Q000008:administration & dosage; D011897:Random Allocation; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D014047:Tolnaftate / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D005839:Gentamicins; D014047:Tolnaftate; D009761:Nystatin; D007464:Clioquinol; D001624:Betamethasone Valerate; D009355:Neomycin; D006206:Halcinonide